BBVA USA Bancshares’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $669K | Sell |
16,411
-2,344
| -12% | -$95.6K | 0.03% | 356 |
|
|
2020
Q4 | $850K | Sell |
18,755
-498
| -3% | -$22.6K | 0.04% | 310 |
|
|
2020
Q3 | $689K | Buy |
19,253
+792
| +4% | +$28.3K | 0.04% | 316 |
|
|
2020
Q2 | $697K | Buy |
18,461
+654
| +4% | +$24.7K | 0.04% | 309 |
|
|
2020
Q1 | $515K | Buy |
17,807
+437
| +3% | +$12.6K | 0.04% | 314 |
|
|
2019
Q4 | $900K | Sell |
17,370
-1,525
| -8% | -$79K | 0.05% | 281 |
|
|
2019
Q3 | $1.04M | Buy |
18,895
+3,945
| +26% | +$217K | 0.07% | 224 |
|
|
2019
Q2 | $607K | Buy |
14,950
+2,213
| +17% | +$89.9K | 0.04% | 338 |
|
|
2019
Q1 | $385K | Buy |
12,737
+3,137
| +33% | +$94.8K | 0.02% | 406 |
|
|
2018
Q4 | $323K | Sell |
9,600
-6,089
| -39% | -$205K | 0.02% | 404 |
|
|
2018
Q3 | $662K | Buy |
15,689
+47
| +0.3% | +$1.98K | 0.04% | 338 |
|
|
2018
Q2 | $500K | Sell |
15,642
-6,138
| -28% | -$196K | 0.03% | 368 |
|
|
2018
Q1 | $1.08M | Buy |
21,780
+1,072
| +5% | +$53.3K | 0.07% | 246 |
|
|
2017
Q4 | $1.12M | Buy |
20,708
+2,451
| +13% | +$132K | 0.07% | 242 |
|
|
2017
Q3 | $1.06M | Buy |
18,257
+3,227
| +21% | +$187K | 0.07% | 253 |
|
|
2017
Q2 | $741K | Buy |
15,030
+6,852
| +84% | +$338K | 0.05% | 310 |
|
|
2017
Q1 | $355K | Buy |
+8,178
| New | +$355K | 0.02% | 422 |
|